September 25, 2016 4:05 AM ET


Company Overview of Sugen, Inc.

Company Overview

Sugen, Inc. went out of business. Sugen, Inc. is engaged in the discovery and development of small molecule drugs, which targeted specific cellular signal transduction pathways. Sugen, Inc. formerly operated as a subsidiary of Pharmacia & Upjohn, Inc. The ownership of Sugen, Inc. passed to Pfizer, Inc. as part of its acquisition of Pharmacia Corporation in April 2003. Sugen, Inc. operates as a subsiairy of Pfizer Inc.

351 Galveston Drive

Redwood City, CA 94063

United States



Key Executives for Sugen, Inc.

Sugen, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
20n Labs, Inc. United States
23andMe, Inc. United States
2C Tech Corporation, Inc. United States
3-V Biosciences, Inc. United States
3D Bio Holdings LLC United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Sugen, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at